nitinol and Liver-Diseases

nitinol has been researched along with Liver-Diseases* in 2 studies

Other Studies

2 other study(ies) available for nitinol and Liver-Diseases

ArticleYear
Hepatocolic fistula managed with a novel Padlock® device for endoscopic closure.
    Revista espanola de enfermedades digestivas, 2017, Volume: 109, Issue:10

    Recent advances in endoscopic therapeutics allow conditions such as fistulas of the digestive system to be treated endoscopically. These cases were recently managed with surgery. The Padlock® system includes a nitinol clip that was recently introduced for endoscopic therapy. There are few reports with regard to its use in the daily clinical practice. We report a case of a colonic fistula that was endoscopically managed with this novel over-the-scope nitinol clip system.

    Topics: Aged; Alloys; Colonic Diseases; Endoscopy, Gastrointestinal; Female; Humans; Intestinal Fistula; Liver Diseases; Surgical Instruments

2017
Use of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience.
    Cardiovascular and interventional radiology, 2008, Volume: 31 Suppl 2

    Four children, three boys and one girl, with a median age of 9 years 8 months, underwent transjugular intrahepatic portosystemic shunt creation with an expanded polytetrafluoroethylene (e-PTFE)-covered nitinol stent. The stent-graft was successfully placed in all four patients without any complication. Clinical and biochemical improvement was noted in all four patients during follow-up. Radiological follow-up with use of duplex ultrasound showed a recurrent stenosis of the shunt 180 days after stent-graft implantation in one patient. This was treated with placement of an additional stent-graft, re-expanding completely the recurrent stenosis. In the other three patients, the stent-graft remained fully patent until the end of the study or until orthotopic liver transplantation. These preliminary results suggest that use of the Viatorr ePTFE-covered stent-graft in children is safe and feasible, with potentially the same high patency rate and improved clinical outcome as reported in adult patients.

    Topics: Adolescent; Alloys; Angiography; Child; Child, Preschool; Female; Humans; Liver Diseases; Male; Polytetrafluoroethylene; Portasystemic Shunt, Transjugular Intrahepatic; Recurrence; Stents

2008